Stockscreener 앱 받기
0.8024
0.30%
0.0024
시간 외 거래:
.81
0.0076
+0.95%
전일 마감가:
$0.80
열려 있는:
$0.8042
하루 거래량:
311.21K
Relative Volume:
0.33
시가총액:
$67.77M
수익:
$153.73M
순이익/손실:
$-106.79M
주가수익비율:
-0.4508
EPS:
-1.78
순현금흐름:
$-115.93M
1주 성능:
-0.94%
1개월 성능:
+2.28%
6개월 성능:
-59.68%
1년 성능:
-75.08%
1일 변동 폭
$0.7978
$0.8402
1주일 범위
$0.7925
$0.8695
52주 변동 폭
$0.5231
$5.17
Sutro Biopharma Inc Stock (STRO) Company Profile
명칭
Sutro Biopharma Inc
전화
650-392-8412
주소
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
STRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
0.8024 | 69.06M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-16 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-03-14 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-05-08 | 개시 | BofA Securities | Buy |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-06 | 개시 | Oppenheimer | Outperform |
| 2023-03-21 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | 재개 | Wells Fargo | Overweight |
| 2021-06-18 | 개시 | H.C. Wainwright | Buy |
| 2020-12-03 | 개시 | Stifel | Buy |
| 2020-09-02 | 개시 | Jefferies | Buy |
| 2020-07-16 | 개시 | Wells Fargo | Overweight |
| 2020-01-13 | 개시 | SunTrust | Buy |
| 2019-10-07 | 개시 | BTIG Research | Buy |
| 2019-07-18 | 개시 | Deutsche Bank | Buy |
| 2019-04-29 | 개시 | H.C. Wainwright | Buy |
| 2018-10-22 | 개시 | JMP Securities | Mkt Outperform |
| 2018-10-22 | 개시 | Piper Jaffray | Overweight |
| 2018-10-22 | 개시 | Wedbush | Outperform |
모두보기
Sutro Biopharma Inc 주식(STRO)의 최신 뉴스
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates - MSN
Sutro Biopharma's Strategic Turnaround: A Path to Profitability Amidst Industry Challenges - AInvest
Sutro Biopharma’s Strategic Shift and Pipeline Developments: A Hold Rating Amid Transitional Phase - TipRanks
Sutro Biopharma 2025 Q2 Earnings Significant Net Loss Reduction - AInvest
Sutro Biopharma Advances ADC Pipeline and Reports Q2 2025 Results - TipRanks
SUTRO BIOPHARMA, INC. SEC 10-Q Report - TradingView
Sutro Biopharma earnings beat by $0.27, revenue topped estimates - Investing.com Canada
SUTRO BIOPHARMA Earnings Results: $STRO Reports Quarterly Earnings - Quiver Quantitative
Sutro Biopharma Reports Second Quarter 2025 Financial Results and Advances Pipeline with Strategic Initiatives - Quiver Quantitative
Sutro Reports 148% Revenue Growth as ADC Pipeline Expands, FDA Partnership Accelerates Development - Stock Titan
Chart overlay techniques for tracking Sutro Biopharma Inc.Low Drawdown Picks with Weekly Updates - Newser
Has Sutro Biopharma Inc. found a price floorTechnical Safety Zone Pattern Recognition - Newser
Chart based analysis of Sutro Biopharma Inc. trendsReversal Pattern Insights with Entry Tips - Newser
Pattern recognition hints at Sutro Biopharma Inc. upsideEquity Market Return Forecast Model Update - Newser
Real time breakdown of Sutro Biopharma Inc. stock performanceHigh Yield Signals with Entry Timing - Newser
Real time scanner hits for Sutro Biopharma Inc. explainedBreakout Watcher with Entry and Exit Alerts - Newser
Sutro Biopharma Inc. Inches Above Key Support — Safe to HoldConfirmed Setup With Expert Accuracy Supported - beatles.ru
Using Ichimoku Cloud for Sutro Biopharma Inc. technicalsFast Return Equity Forecast With Logic - Newser
News impact scoring models applied to Sutro Biopharma Inc.Free Daily Momentum Screener With Alerts - Newser
Combining price and volume data for Sutro Biopharma Inc.Price Spike Prediction for Active Traders - Newser
Has Sutro Biopharma Inc. formed a bullish divergenceSwing Watchlist With Tight Stop Placement - Newser
Sutro Biopharma Inc. stock trend outlook and recovery pathFree Reliable Investment Entry Point Signals - Newser
Is Sutro Biopharma Inc. stock overvalued or undervaluedTake advantage of unprecedented market momentum - Jammu Links News
What makes Sutro Biopharma Inc. stock price move sharplyFree Community Strategy With High Win Rate - Newser
What institutional investors are buying Sutro Biopharma Inc. stockMaximize gains with proven stock analysis - Jammu Links News
What is the risk reward ratio of investing in Sutro Biopharma Inc. stockFree Stock Market Query - Jammu Links News
Does Sutro Biopharma Inc. stock perform well during market downturnsBuild a diversified portfolio for sustainable growth - Jammu Links News
How does Sutro Biopharma Inc. generate profit in a changing economyExceptional return forecasts - Jammu Links News
How Sutro Biopharma Inc. stock performs during market volatilityReversal Signal Prediction Based on Volume - newser.com
How strong is Sutro Biopharma Inc. company’s balance sheetSuperior capital gains - Jammu Links News
What are the technical indicators suggesting about Sutro Biopharma Inc.Achieve exceptional returns with expert guidance - Jammu Links News
Is Sutro Biopharma Inc. a growth stock or a value stockMaximize returns with disciplined trading approaches - Jammu Links News
How many analysts rate Sutro Biopharma Inc. as a “Buy”Outstanding investment returns - Jammu Links News
Why Sutro Biopharma Inc. stock attracts strong analyst attentionShort Term Gain Strategy with AI Logic - Newser
Institutional scanner results for Sutro Biopharma Inc.Free Stock Portfolio Allocation Guidance - Newser
Understanding Sutro Biopharma Inc.’s price movementFree Stock Portfolio Allocation Guidance - Newser
Is Sutro Biopharma Inc. forming a bottoming baseDaily Technical Forecast for Quick Gains - Newser
Is Sutro Biopharma Inc. a candidate for recovery playLow Drawdown Stock Screener with Analysis - Newser
Sutro Biopharma Inc (STRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):